MAPT and Alzheimer disease: A previous meta-analysis (Koychev et al., 2020) also showed that the levels of total tau (t-tau) and phosphorylated tau (p-tau) proteins in the cerebrospinal fluid (CSF) could significantly distinguish AD patients from healthy individuals.